---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-082871"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2023-07-21T23:59:59+00:00"
generated_at: "2026-06-13T05:04:55.906089+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# MedTech Acquisition regains Nasdaq MVLS compliance threshold

## Summary
- Received Nasdaq notice on June 14, 2023 for non-compliance with $35M MVLS requirement.
- Nasdaq confirmed MVLS >=$35M for 15 consecutive business days (June 26-July 14, 2023).
- On July 17, 2023, Nasdaq notified compliance is regained; matter closed.

## SEC filing metadata
- accession: 0001104659-23-082871
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2023-07-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465923082871/0001104659-23-082871-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465923082871/tm2321746d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-082871
- JSON: https://secwatch.observer/filing/0001104659-23-082871.json
- Plain text: https://secwatch.observer/filing/0001104659-23-082871.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.